Compare TCRX & DSWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCRX | DSWL |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | Macau |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 49.6M |
| IPO Year | 2021 | 2000 |
| Metric | TCRX | DSWL |
|---|---|---|
| Price | $0.31 | $3.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 9.2K |
| Earning Date | 05-08-2026 | 06-17-2026 |
| Dividend Yield | N/A | ★ 5.90% |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,325,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | $4.59 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.29 | $2.84 |
| 52 Week High | $2.57 | $4.09 |
| Indicator | TCRX | DSWL |
|---|---|---|
| Relative Strength Index (RSI) | 21.36 | 54.68 |
| Support Level | N/A | $3.20 |
| Resistance Level | $0.82 | $3.46 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 4.94 | 85.29 |
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Deswell Industries Inc comprise the manufacturing and sales of injection-molded plastic parts and components and electronic products assembling. The manufacturing activities are subcontracted to operating in the Macao Special Administrative Region (Macao) of the PRC. It produce a wide variety of plastic parts and components that are used in the manufacture of consumer and industrial products, using different plastic injection technologies, such as film injection, integrated injection and insert injection. It has two segments: plastic injection molding and electronic products assembling. It has generates majority of profit from Electronic Segment. It has presence in China, United States, Europe, Hong Kong, United Kingdom, Canada, and Others of which majority of sales is from China.